|
End-of-day quote
Berne S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 135.88 CHF | -2.33% |
|
-1.13% | -6.19% |
| Sep. 30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Sep. 30 | Major drugmakers turn to China for licensing deals | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
AstraZeneca PLC(AZN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
AstraZeneca PLC(AZN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
AstraZeneca PLC(AZN)
EBIT
Dividend / Share (DPS)
Data source:
AstraZeneca PLC(AZN)
Cash or Net Debt
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
- Consensus AstraZeneca PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
